- AMI Orange County opening for classes on June 26, 2025
- AMI Atlanta opening for classes on July 21, 2025
IRVINE, Calif., April 30, 2025 /PRNewswire/ -- In pursuit of excellence in medical aesthetics education, Allergan Aesthetics, an AbbVie company, is proud to introduce the inaugural Allergan Medical Institute® (AMI) Faculty for the AMI Orange County and AMI Atlanta Training Centers. With a steadfast commitment to advancing the field and responsibly growing the aesthetics industry, this group of top educators has been chosen to help guide the development of the next generation of aesthetic injectors and shape the evolution of aesthetic education through their expertise and insights.
"We are able to truly elevate the aesthetics education experience through our incredible partners who bring a focus on real-world practice insights and clinical differentiation of the Allergan Aesthetics portfolio to every training engagement," said Matt Williams, Vice President, Allergan Medical Institute. "With nearly 500 best-in-class faculty driving our efforts, AMI offers a comprehensive training continuum that meets trainees wherever they are in their educational journey. This would not be possible without the unparallelled faculty expertise delivered through our training centers, large-scale programs, in providers' clinics and through AMI Online education modules."
Honoring the Expertise of the AMI Training Center Faculty
The AMI Training Centers Faculty has been carefully selected based on their significant experience and commitment to elevating the aesthetics industry through training. Their extensive expertise in hands-on training, leading large-scale educational programs, and exceptional presentation skills will enhance the AMI Training Center experience for trainees.
Each training center will have a dedicated Allergan Aesthetics Clinical Education Team that will provide foundational learning principles aligned with Allergan Aesthetics products and standards. The AMI Training Center Faculty will supplement and enhance training with in-practice expertise and guidance to deliver the best in medical aesthetics education. In addition, AMI Training Center Faculty will still play a critical role within AMI's robust educational offerings in the field, in practice, and beyond.
Meet the AMI Training Center Faculty
Allergan Aesthetics is honored to welcome Dr. Saami Khalifian, Medical Director for the U.S. AMI Training Centers, alongside 38 additional AMI Faculty members who will share their knowledge, experience, and dedication to advancing aesthetic medicine.
These AMI Training Center Faculty members will lead the AMI Immersive Programs including Foundational Injectables, Evolving Injectables, Patient Safety and Advocacy, and Interactive Anatomy, in addition to continuing to support AMI programs outside of the centers.
Maryellen Bishop, PA-C, MSHS––Atlanta, GA
Charles Boyd, MD––Detroit, MI
Brie Chandler, PA-C, DMSc––Nashville, TN
Younghoon Cho, MD, PhD––Greater Houston, TX
Shawna Chrisman, NP––Sacramento, CA
Jennifer Cobbs, MS, PA-C––Atlanta, GA
Audrey Coleman, PA-C––Jacksonville, FL
Tara Delle Chiaie, DNP, MSN, FNP-BC, APRN, ABAAHP––Hampton, NH
Jennifer DeMaio, RN, MSN, FNP-C, CANS––Westfield, NJ
Michelle Doran, MSN, APRN, BC, CANS––Salem, MA
Rachel Duke, MS, NP, CANS––Greater Richmond, VA
Amy Faircloth, RN, BSN––Atlanta, GA
John Fezza, MD––Sarasota, FL
Leslie Fletcher, MSN, RN, AGNP-BC––Los Angeles, CA
Stefanie Gatica, DNP, FNP-C––Greater Des Moines, IA
Melissa Giordano, BSN, RN, CANS, CPSN––Paramus, NJ
Meredith Harris, MSN, APRN––Raleigh, NC
Brandice Harrison, PA-C––Lexington, KY
Zainab Jishi, MS, PA-C––Greater Detroit, MI
Saami Khalifian, MD, FAAD––San Diego, CA
Trevor Larsen, RN––Greater Las Vegas, NV
Nicola Lowrey, MPAP, PA-C––Manhattan Beach, CA
Jessica McCarry, PA-C––St. Petersburg, FL
Kathleen Morno, MD––Greater Chicago, IL
Erica Oakes, RN, CANS––Knoxville, TN
Lori Phoenix, RN––Greater Boston, MA
Marty Raymond, RN, BSN, CANS––Greater Denver, CO
Gary Rubin, PA-C, MMS––Greater Orlando, FL
David Saadat, MD––Beverly Hills, CA
Emily Schultz, RN, CANS––Ontario, Canada
Misty Shedd, APRN, MSN, CANS––Dallas, TX
Robyn Siperstein, MD, FAAD––Boca Raton, FL
Belinda Stewart, MSN, RN––Tulsa, OK
Ana Torres, PA-C––Laguna Beach, CA
Heather Tucker, BSN, RN––Greater Nashville, TN
Danielle White, MSN, APRN, FNP-C––Fort Lauderdale, FL
Riley Worth, APRN, MSN, FNP-C, FNP-BC––Greater Salt Lake City, UT
Steve Yoelin, MD––Newport Beach, CA
For an upcoming program schedule and to sign up for courses, visit trainingcenters.amionline.com/
About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.AllerganAesthetics.com.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
About Allergan Medical Institute (AMI)
AMI is the training arm of Allergan Aesthetics, delivering on its commitment to excellence in aesthetics education. AMI empowers aesthetics providers and business owners with innovative training offerings across Allergan Aesthetics robust portfolio of products to maximize educational impact and elevate the standard of exemplary patient experiences. For more information visit https://us.allerganmedicalinstitute.com/us/en/splash-page.html.
About AMI Online
AMI Online is a comprehensive learning platform featuring in-depth education and training on the Allergan Aesthetics Portfolio of Products available on demand, 24/7. It is designed to provide an adaptable, personalized learning experience that helps injectors of all levels further their knowledge, refine their skills, and advance their expertise. AMI Online enables injectors and their staff to review injection techniques, test their knowledge, earn certificates, and stay up to date with upcoming educational events. Allergan Medical Institute® Faculty offer expert training through engaging, personalized content available to all AMI Online members for free.
Forward-Looking Statements
Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "anticipate," "project" and similar expressions and uses of future or conditional verbs, generally identify forward-looking statements. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties include, but are not limited to, challenges to intellectual property, competition from other products, difficulties inherent in the research and development process, adverse litigation or government action, changes to laws and regulations applicable to our industry, the impact of global macroeconomic factors, such as economic downturns or uncertainty, international conflict, trade disputes and tariffs, and other uncertainties and risks associated with global business operations. Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2024 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its Quarterly Reports on Form 10-Q and in other documents that AbbVie subsequently files with the Securities and Exchange Commission that update, supplement or supersede such information. AbbVie undertakes no obligation, and specifically declines, to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law.
U.S. Media:
Ember Garrett
Communications and Public Relations
garrett_ember@allergan.com
Kate McShane
Corporate Communications
Kate.mcshane@allergan.com
